Assembly Biosciences (ASMB) Intangibles (2014 - 2021)
Assembly Biosciences (ASMB) posted quarterly Intangibles of $29.0 million for Q3 2021, little changed year-over-year from $29.0 million in Q3 2020, and little changed quarter-over-quarter from $29.0 million in Q2 2021.
Assembly Biosciences (ASMB) Intangibles (2014 - 2021) Analysis & Trends
Assembly Biosciences' Intangibles history runs 8 years deep, the most recent figure standing at $29.0 million for Q3 2021.
- In Q3 2021, Intangibles changed 0.0% year-over-year to $29.0 million; the TTM figure through Sep 2021 stood at $29.0 million (changed 0.0% YoY), while the FY2020 annual figure was $29.0 million, changed 0.0% from the prior year.
- Intangibles for Q3 2021 stood at $29.0 million, roughly flat from $29.0 million in the prior quarter.
- The five-year high for Intangibles was $29.0 million in Q1 2017, with the low at $29.0 million in Q1 2017.
- The 5-year median for Intangibles is $29.0 million (2017), against an average of $29.0 million.
- Peak annual rise in Intangibles reached 0.0% in 2017, while the deepest fall reached 0.0% in 2017.
- Assembly Biosciences' Intangibles stood at $29.0 million in 2017, then changed by 0.0% to $29.0 million in 2018, then changed by 0.0% to $29.0 million in 2019, then changed by 0.0% to $29.0 million in 2020, then changed by 0.0% to $29.0 million in 2021.
- Business Quant data shows ASMB's Intangibles at $29.0 million in Q3 2021, $29.0 million in Q2 2021, and $29.0 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 266.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 63.28 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 60.96 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 93.49 Mn |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 29.00 Mn |
| Jun 30, 2021 | 29.00 Mn |
| Mar 31, 2021 | 29.00 Mn |
| Dec 31, 2020 | 29.00 Mn |
| Sep 30, 2020 | 29.00 Mn |
| Jun 30, 2020 | 29.00 Mn |
| Mar 31, 2020 | 29.00 Mn |
| Dec 31, 2019 | 29.00 Mn |
| Sep 30, 2019 | 29.00 Mn |
| Jun 30, 2019 | 29.00 Mn |
| Mar 31, 2019 | 29.00 Mn |
| Dec 31, 2018 | 29.00 Mn |
| Sep 30, 2018 | 29.00 Mn |
| Jun 30, 2018 | 29.00 Mn |
| Mar 31, 2018 | 29.00 Mn |
| Dec 31, 2017 | 29.00 Mn |
| Sep 30, 2017 | 29.00 Mn |
| Jun 30, 2017 | 29.00 Mn |
| Mar 31, 2017 | 29.00 Mn |
| Dec 31, 2016 | 29.00 Mn |